Search research articles
Contact Us
Filters
Showing results (651-660 of 678) with videos related to
Page
of 68
Sort By:
Blood Advances
|
September 23, 2018
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group
Tao Wu, Yong Yang, Su-Yu Zhu, et al.
The Journal of Clinical Investigation
|
May 13, 2020
Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma
Ming-Yang Li, Lin-Ni Fan, Dong-Hui Han, et al.
Zhonghua Nei Ke Za Zhi
|
January 19, 2013
[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study]
Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2017
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
Loren K Mell, Igor Sirák, Lichun Wei, et al.
Zhonghua Nei Ke Za Zhi
|
May 29, 2013
[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study]
Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
JCO Global Oncology
|
January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis
Jing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Blood Advances
|
July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Shu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Leukemia
|
August 3, 2021
Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Haematologica
|
March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
Xin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
Page
of 68
Search research articles
Search
Showing results (651-660 of 678) with videos related to
Sort By:
Page
of 68
Blood Advances
|
September 23, 2018
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group
Tao Wu, Yong Yang, Su-Yu Zhu, et al.
The Journal of Clinical Investigation
|
May 13, 2020
Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma
Ming-Yang Li, Lin-Ni Fan, Dong-Hui Han, et al.
Zhonghua Nei Ke Za Zhi
|
January 19, 2013
[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study]
Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2017
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
Loren K Mell, Igor Sirák, Lichun Wei, et al.
Zhonghua Nei Ke Za Zhi
|
May 29, 2013
[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study]
Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
JCO Global Oncology
|
January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis
Jing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.
Blood Advances
|
July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Shu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Leukemia
|
August 3, 2021
Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Haematologica
|
March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
Xin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
Page
of 68